McKinsey Opened a Door in Its Firewall Between Pharma Clients and Regulatorsnews2022-04-13T22:06:06+00:00April 13th, 2022|The New York Times|
Companies Finalize $26 Billion Deal With States and Cities to End Opioid Lawsuitsnews2022-02-25T14:12:55+00:00February 25th, 2022|The New York Times|
Senate Confirms Califf as F.D.A. Chief in Tight Votenews2022-02-15T18:47:59+00:00February 15th, 2022|The New York Times|
C.D.C. Proposes New Guidelines for Treating Pain, Including Opioid Usenews2022-02-10T13:55:27+00:00February 10th, 2022|The New York Times|
F.D.A. Nominee Faces Steep Climb to Senate Confirmationnews2022-02-03T17:31:17+00:00February 3rd, 2022|The New York Times|
Tribes Reach $590 Million Opioid Settlement With Johnson & Johnsonnews2022-02-01T22:52:05+00:00February 1st, 2022|The New York Times|
They Made the Most of the Opioid Crisis. Until They Didn’t.news2022-01-19T15:30:03+00:00January 19th, 2022|The New York Times|
Teva Pharmaceuticals Found Liable in Landmark Opioid Trialnews2021-12-30T23:06:33+00:00December 30th, 2021|The New York Times|
Judge Overturns Purdue Pharma’s Opioid Settlementnews2021-12-17T12:52:42+00:00December 17th, 2021|The New York Times|
Judge Overturns Purdue Pharma’s Opioid Settlementnews2021-12-17T12:52:42+00:00December 17th, 2021|The New York Times|
